![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 51, 42026-42035, December 23, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1
From the
Carolinas Neuromuscular/ALS-MDA Center, Carolinas Medical Center, Charlotte, North Carolina 28203 and the Free Radicals in Medicine Core,
Division of Cardiology, ¶Center for Neurodegenerative Disease, Emory University, Atlanta, Georgia 30322
Chronic infusion of rotenone (Rot) to Lewis rats reproduces many features of Parkinson disease. Rot (3 mg/kg/day) was infused subcutaneously to male Lewis rats for 6 days using Alzet minipumps. Control rats received the vehicle only. Presence of 0.1% bovine serum albumin during the isolation procedure completely removed rotenone bound to the mitochondria. Therefore all functional changes observed were aftereffects of rotenone toxicity in vivo. In Rot rat brain mitochondria (Rot-RBM) there was a 30-40% inhibition of respiration in State 3 and State 3U with Complex I (Co-I) substrates and succinate. Rot did not affect the State 4
of RBM and rat liver mitochondria (RLM). However, Rot-RBM required two times less Ca2+ to initiate permeability transition (mPT). There was a 2-fold increase in
or H2O2 generation in Rot-RBM oxidizing glutamate. Rot infusion affected RLM little. Our results show that in RBM, the major site of reactive oxygen species generation with glutamate or succinate is Co-I. We also found that Co-II generates substantial amounts of reactive oxygen species that increased 2-fold in the Rot-RBM. Our data suggest that the primary mechanism of the Rot toxic effect on RBM consists in a significant increase of
generation that causes damage to Co-I and Co-II, presumably at the level of 4Fe-4S clusters. Decreased respiratory activity diminishes resistance of RBM to Ca2+ and thus increases probability of mPT and apoptotic cell death. We suggest that the damage to Co-I and Co-II shifts
generation from the CoQ10 sites to more proximal sites, such as flavines, and makes it independent of the RBM functional state.
Received for publication, August 5, 2005 , and in revised form, October 20, 2005.
* This work was supported by National Institutes of Health NIEHS Grant ES012068 and a grant from the Picower Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: 1000 Blythe Blvd., Charlotte, NC 28203. Tel.: 704-355-5902; Fax: 704-446-6255; E-mail: alexander.panov{at}carolinashealthcare.org.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. K. Doughan, D. G. Harrison, and S. I. Dikalov Molecular Mechanisms of Angiotensin II-Mediated Mitochondrial Dysfunction: Linking Mitochondrial Oxidative Damage and Vascular Endothelial Dysfunction Circ. Res., February 29, 2008; 102(4): 488 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watabe and T. Nakaki Mitochondrial Complex I Inhibitor Rotenone-Elicited Dopamine Redistribution from Vesicles to Cytosol in Human Dopaminergic SH-SY5Y Cells J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 499 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Perez-Ortiz, P. Tranque, M. Burgos, C. F. Vaquero, and J. Llopis Glitazones Induce Astroglioma Cell Death by Releasing Reactive Oxygen Species from Mitochondria: Modulation of Cytotoxicity by Nitric Oxide Mol. Pharmacol., August 1, 2007; 72(2): 407 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.M. Janssen, F. J.M. Trijbels, R. C.A. Sengers, J. A.M. Smeitink, L. P. van den Heuvel, L. T.M. Wintjes, B. J.M. Stoltenborg-Hogenkamp, and R. J.T. Rodenburg Spectrophotometric Assay for Complex I of the Respiratory Chain in Tissue Samples and Cultured Fibroblasts Clin. Chem., April 1, 2007; 53(4): 729 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Panov, S. Dikalov, N. Shalbuyeva, R. Hemendinger, J. T. Greenamyre, and J. Rosenfeld Species- and tissue-specific relationships between mitochondrial permeability transition and generation of ROS in brain and liver mitochondria of rats and mice Am J Physiol Cell Physiol, February 1, 2007; 292(2): C708 - C718. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Keeney, J. Xie, R. A. Capaldi, and J. P. Bennett Jr Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci., May 10, 2006; 26(19): 5256 - 5264. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |